FOSAPREPITANT for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where FOSAPREPITANT was used for Breast cancer.
Most Reported Side Effects for FOSAPREPITANT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 195 | 40.0% | 83 | 143 |
| Infusion related reaction | 167 | 34.3% | 64 | 130 |
| Hypersensitivity | 157 | 32.2% | 81 | 148 |
| Duodenal ulcer perforation | 155 | 31.8% | 92 | 155 |
| Confusional state | 149 | 30.6% | 85 | 149 |
| Glossodynia | 149 | 30.6% | 86 | 149 |
| Folliculitis | 146 | 30.0% | 83 | 146 |
| Arthralgia | 144 | 29.6% | 79 | 143 |
| Blister | 144 | 29.6% | 81 | 144 |
| Discomfort | 144 | 29.6% | 80 | 143 |
| Helicobacter infection | 144 | 29.6% | 81 | 144 |
| Hepatic enzyme increased | 144 | 29.6% | 81 | 144 |
| Alopecia | 143 | 29.4% | 79 | 143 |
| Arthropathy | 143 | 29.4% | 80 | 143 |
| Fatigue | 143 | 29.4% | 78 | 141 |
Other Indications for FOSAPREPITANT
Rheumatoid arthritis (117)
Product used for unknown indication (110)
Prophylaxis of nausea and vomiting (82)
Nausea (22)
Vomiting (17)
Premedication (16)
Chemotherapy side effect prophylaxis (14)
Antiemetic supportive care (12)
Chemotherapy (6)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)